LAMEA Liver Disease Diagnostics Market By End User (Hospitals, Laboratories and Other End Users), By Diagnosis Technique (Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques), By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Liver Disease Diagnostics Market would witness market growth of 7.6% CAGR during the forecast period (2020-2026).
Increasing the prevalence of the liver disease has made it important to increase awareness. Government and non-profit organizations play a vital role in a growing understanding of liver disease around the world. These organizations promote awareness of liver-related diseases and support research and development in the prevention, treatment, and cure of liver disease.
In underdeveloped countries, however, the presence of an unmet clinical need for liver disease is likely to fuel the demand for diagnosis and treatment of liver disease. In addition to that, the rise to people's disposable income is projected to further expand the demand because they become more inclined to invest freely in advanced treatment. Furthermore, the growing acceptance of unhealthy lifestyles is described as a core factor of growth for liver disease diagnostics and treatment.
Liver disease in the United Kingdom has increased dramatically, particularly in people under 65 years of age — a marked contrast to all other major causes of death that have decreased in younger age groups. The epidemic was caused by alcohol, obesity and hepatitis C. LFTs are usually abnormal due to a number of causes, such as drinking too much, fatty liver due to obesity, infections, rare liver diseases, and certain cancers — but they may be a symptom of potentially fatal liver disease.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited
Scope of the Study
Market Segmentation:
By End User
Increasing the prevalence of the liver disease has made it important to increase awareness. Government and non-profit organizations play a vital role in a growing understanding of liver disease around the world. These organizations promote awareness of liver-related diseases and support research and development in the prevention, treatment, and cure of liver disease.
In underdeveloped countries, however, the presence of an unmet clinical need for liver disease is likely to fuel the demand for diagnosis and treatment of liver disease. In addition to that, the rise to people's disposable income is projected to further expand the demand because they become more inclined to invest freely in advanced treatment. Furthermore, the growing acceptance of unhealthy lifestyles is described as a core factor of growth for liver disease diagnostics and treatment.
Liver disease in the United Kingdom has increased dramatically, particularly in people under 65 years of age — a marked contrast to all other major causes of death that have decreased in younger age groups. The epidemic was caused by alcohol, obesity and hepatitis C. LFTs are usually abnormal due to a number of causes, such as drinking too much, fatty liver due to obesity, infections, rare liver diseases, and certain cancers — but they may be a symptom of potentially fatal liver disease.
Based on End User, the market is segmented into Hospitals, Laboratories and Other End Users. Based on Diagnosis Technique, the market is segmented into Imaging, Biopsy, Endoscopy, Laboratory tests and Other Diagnosis Techniques. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Boston Scientific Corporation, Siemens AG (Siemens Healthineers), Bayer AG, Merck & Co., Inc., Sanofi S.A., Novartis AG, Pfizer, Inc., and Randox laboratories limited
Scope of the Study
Market Segmentation:
By End User
- Hospitals, Laboratories and Other End Users
- Imaging
- Biopsy
- Endoscopy
- Laboratory tests and
- Other Diagnosis Techniques
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
- Boston Scientific Corporation
- Siemens AG (Siemens Healthineers)
- Bayer AG
- Merck & Co., Inc.
- Sanofi S.A.
- Novartis AG
- Pfizer, Inc.
- Randox laboratories limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Liver Disease Diagnostics Market, by End User
1.4.2 LAMEA Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 LAMEA Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 LAMEA Hospitals Market by Country
3.2 LAMEA Laboratories Market by Country
3.3 LAMEA Other End Users Market by Country
CHAPTER 4. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 LAMEA Imaging Market by Country
4.2 LAMEA Biopsy Market by Country
4.3 LAMEA Endoscopy Market by Country
4.4 LAMEA Laboratory tests Market by Country
4.5 LAMEA Other Diagnosis Techniques Market by Country
CHAPTER 5. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY
5.1 Brazil Liver Disease Diagnostics Market
5.1.1 Brazil Liver Disease Diagnostics Market by End User
5.1.2 Brazil Liver Disease Diagnostics Market by Diagnosis Technique
5.2 Argentina Liver Disease Diagnostics Market
5.2.1 Argentina Liver Disease Diagnostics Market by End User
5.2.2 Argentina Liver Disease Diagnostics Market by Diagnosis Technique
5.3 UAE Liver Disease Diagnostics Market
5.3.1 UAE Liver Disease Diagnostics Market by End User
5.3.2 UAE Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Saudi Arabia Liver Disease Diagnostics Market
5.4.1 Saudi Arabia Liver Disease Diagnostics Market by End User
5.4.2 Saudi Arabia Liver Disease Diagnostics Market by Diagnosis Technique
5.5 South Africa Liver Disease Diagnostics Market
5.5.1 South Africa Liver Disease Diagnostics Market by End User
5.5.2 South Africa Liver Disease Diagnostics Market by Diagnosis Technique
5.6 Nigeria Liver Disease Diagnostics Market
5.6.1 Nigeria Liver Disease Diagnostics Market by End User
5.6.2 Nigeria Liver Disease Diagnostics Market by Diagnosis Technique
5.7 Rest of LAMEA Liver Disease Diagnostics Market
5.7.1 Rest of LAMEA Liver Disease Diagnostics Market by End User
5.7.2 Rest of LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Liver Disease Diagnostics Market, by End User
1.4.2 LAMEA Liver Disease Diagnostics Market, by Diagnosis Technique
1.4.3 LAMEA Liver Disease Diagnostics Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER
3.1 LAMEA Hospitals Market by Country
3.2 LAMEA Laboratories Market by Country
3.3 LAMEA Other End Users Market by Country
CHAPTER 4. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE
4.1 LAMEA Imaging Market by Country
4.2 LAMEA Biopsy Market by Country
4.3 LAMEA Endoscopy Market by Country
4.4 LAMEA Laboratory tests Market by Country
4.5 LAMEA Other Diagnosis Techniques Market by Country
CHAPTER 5. LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY
5.1 Brazil Liver Disease Diagnostics Market
5.1.1 Brazil Liver Disease Diagnostics Market by End User
5.1.2 Brazil Liver Disease Diagnostics Market by Diagnosis Technique
5.2 Argentina Liver Disease Diagnostics Market
5.2.1 Argentina Liver Disease Diagnostics Market by End User
5.2.2 Argentina Liver Disease Diagnostics Market by Diagnosis Technique
5.3 UAE Liver Disease Diagnostics Market
5.3.1 UAE Liver Disease Diagnostics Market by End User
5.3.2 UAE Liver Disease Diagnostics Market by Diagnosis Technique
5.4 Saudi Arabia Liver Disease Diagnostics Market
5.4.1 Saudi Arabia Liver Disease Diagnostics Market by End User
5.4.2 Saudi Arabia Liver Disease Diagnostics Market by Diagnosis Technique
5.5 South Africa Liver Disease Diagnostics Market
5.5.1 South Africa Liver Disease Diagnostics Market by End User
5.5.2 South Africa Liver Disease Diagnostics Market by Diagnosis Technique
5.6 Nigeria Liver Disease Diagnostics Market
5.6.1 Nigeria Liver Disease Diagnostics Market by End User
5.6.2 Nigeria Liver Disease Diagnostics Market by Diagnosis Technique
5.7 Rest of LAMEA Liver Disease Diagnostics Market
5.7.1 Rest of LAMEA Liver Disease Diagnostics Market by End User
5.7.2 Rest of LAMEA Liver Disease Diagnostics Market by Diagnosis Technique
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Acquisition and Mergers:
6.1.5.3 Approvals:
6.2 F. Hoffmann-La Roche Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent strategies and developments:
6.2.5.1 Approvals:
6.3 Boston Scientific Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Acquisition and Mergers:
6.4 Siemens AG (Siemens Healthineers)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.4.5.3 Product Launches and Product Expansions:
6.5 Bayer AG
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 Merck & Co., Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Sanofi S.A.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.8 Novartis AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.9 Pfizer, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Research & Development Expense
6.1 Randox Laboratories Limited
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 4 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 5 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 26 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 27 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 31 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 32 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 33 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 34 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 37 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 38 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 39 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 40 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 41 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 42 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 43 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 44 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 45 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 46 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 49 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 50 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 51 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 52 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 53 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 54 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 55 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 56 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 57 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 58 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 59 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 60 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 61 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 62 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 63 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 64 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 65 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 66 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 67 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 68 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 69 KEY INFORMATION – SIEMENS AG
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION - MERCK & CO., INC.
TABLE 72 KEY INFORMATION – SANOFI S.A.
TABLE 73 KEY INFORMATION – NOVARTIS AG
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 1 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 3 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 4 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 5 LAMEA HOSPITALS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 LAMEA HOSPITALS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 LAMEA LABORATORIES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 LAMEA LABORATORIES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 LAMEA OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 12 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 13 LAMEA IMAGING MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA IMAGING MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA BIOPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 LAMEA BIOPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA ENDOSCOPY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA LABORATORY TESTS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA OTHER DIAGNOSIS TECHNIQUES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 26 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 27 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 28 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 31 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 32 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 33 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 34 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 37 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 38 UAE LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 39 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 40 UAE LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 41 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 42 UAE LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 43 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 44 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 45 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 46 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 48 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 49 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 50 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 51 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 52 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 53 SOUTH AFRICA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 54 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 55 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 56 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 57 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 58 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 59 NIGERIA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 60 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2016 - 2019, USD MILLION
TABLE 61 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET, 2020 - 2026, USD MILLION
TABLE 62 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2016 - 2019, USD MILLION
TABLE 63 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY END USER, 2020 - 2026, USD MILLION
TABLE 64 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2016 - 2019, USD MILLION
TABLE 65 REST OF LAMEA LIVER DISEASE DIAGNOSTICS MARKET BY DIAGNOSIS TECHNIQUE, 2020 - 2026, USD MILLION
TABLE 66 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 67 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 68 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 69 KEY INFORMATION – SIEMENS AG
TABLE 70 KEY INFORMATION – BAYER AG
TABLE 71 KEY INFORMATION - MERCK & CO., INC.
TABLE 72 KEY INFORMATION – SANOFI S.A.
TABLE 73 KEY INFORMATION – NOVARTIS AG
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – RANDOX LABORATORIES LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: SIEMENS AG
